Characterizing a Clinical Trial - Representative, Real-World Population with Heart Failure with Reduced Ejection Fraction

被引：1

作者：

Wells, Quinn S. ^{[1
,2
]}

Farber-Eger, Eric ^{[1
,2
]}

Lipworth, Loren ^{[2
,3
]}

Dluzniewski, Paul ^{[4
]}

Dent, Ricardo ^{[4
]}

Umeijiego, John ^{[4
]}

Cohen, Sarah S. ^{[3
,5
]}

机构：

[1] Vanderbilt Univ, Dept Med, Div Cardiovasc Med, Med Ctr, Nashville, TN USA

[2] Vanderbilt Univ, Med Ctr, Vanderbilt Translat & Clin Cardiovasc Res Ctr VTR, Nashville, TN USA

[3] Vanderbilt Univ, Dept Med, Div Epidemiol, Med Ctr, Nashville, TN 37235 USA

[4] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA 91320 USA

[5] Toxstrategies Inc, Epidstrategies, Cary, NC 27511 USA

来源：

CLINICAL EPIDEMIOLOGY | 2022年 / 14卷

关键词：

heart failure; reduced ejection fraction; real-world evidence; electronic health record; RANDOMIZED INTERVENTION TRIAL; CIBIS-II; MORTALITY; ENALAPRIL; SURVIVAL; METOPROLOL; MORBIDITY; OUTCOMES;

D O I：

10.2147/CLEP.S341919

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

li li li Conclusion: Approximately 40% of RW HFrEF patients met criteria for the GALACTICHF trial. While findings of ongoing clinical trials may be directly generalizable to this sizable proportion of patients, future trials should examine whether the majority of patients with lower prevalence of comorbidities and rate of HF hospitalization could benefit from emerging HF treatments.

引用

页码：39 / 49

页数：11

共 50 条

[1] Real-world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction
Huusko, Jenni
Purmonen, Timo
Toppila, Iiro
Lassenius, Mariann
Ukkonen, Heikki
ESC HEART FAILURE, 2020, 7 (03): : 1039 - 1048
[2] Is the PARADIGM-HF cohort representative of the real-world heart failure patient population?
Rodrigues, Gustavo
Tralhao, Antonio
Aguiar, Carlos
Freitas, Pedro
Ventosa, Antonio
Mendes, Miguel
REVISTA PORTUGUESA DE CARDIOLOGIA, 2018, 37 (06) : 491 - 496
[3] Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction
Mapelli, Massimo
Salvioni, Elisabetta
de Martino, Fabiana
Mattavelli, Irene
Bonomi, Alice
Sassi, Valentina
Gugliandolo, Paola
Vignati, Carlo
Magini, Alessandra
Rovai, Sara
Paolillo, Stefania
Agostoni, Piergiuseppe
JOURNAL OF CARDIOVASCULAR MEDICINE, 2020, 21 (11) : 882 - 888
[4] Treatment of heart failure with reduced ejection fraction
Kim, In-Cheol
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2022, 65 (01): : 9 - 17
[5] Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
Polito, Maria Vincenza
Silverio, Angelo
Rispoli, Antonella
Vitulano, Gennaro
D'Auria, Federica
De Angelis, Elena
Loria, Francesco
Gigantino, Alberto
Bonadies, Domenico
Citro, Rodolfo
Carrizzo, Albino
Galasso, Gennaro
Iaccarino, Guido
Vecchione, Carmine
Ciccarelli, Michele
SCIENTIFIC REPORTS, 2020, 10 (01)
[6] Real-world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
Oh, Jaewon
Lee, Chan Joo
Park, Jin Joo
Lee, Sang Eun
Kim, Min-Seok
Cho, Hyun-Jai
Choi, Jin-Oh
Lee, Hae-Young
Hwang, Kyung-Kuk
Kim, Kye Hun
Yoo, Byung-Su
Choi, Dong-Ju
Baek, Sang Hong
Jeon, Eun-Seok
Kim, Jae-Joong
Cho, Myeong-Chan
Chae, Shung Chull
Oh, Byung-Hee
Kang, Seok-Min
ESC HEART FAILURE, 2022, 9 (02): : 1492 - 1495
[7] Sequencing of medical therapy in heart failure with a reduced ejection fraction
Savage, Henry Oluwasefunmi
Dimarco, Anthony David
Li, Brian
Langley, Samantha
Hardy-Wallace, Amy
Barbagallo, Rossella
Dungu, Jason N.
HEART, 2023, 109 (07) : 511 - 518
[8] Dose titration of sacubitril/valsartan for heart failure with reduced ejection fraction: a real-world study
Wang, Chen
Lin, Zongwei
Miao, Dongxia
Zhang, Hui
Fu, Kang
Zhang, Xinyu
Xiao, Jie
Hu, Yue
Sun, Yijun
Wang, Fen
Lu, Huixia
Ji, Xiaoping
ESC HEART FAILURE, 2023, 10 (03): : 1961 - 1971
[9] EVALUATION OF ANGIOTENSIN RECEPTOR AND NEPRLYSIN INHIBITION (ARNI) IN PATIENTS OF HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) - A REAL-WORLD STUDY
Hafizullah, Mohammad
Aman, Wahaj
Afridi, Hisar
PAKISTAN HEART JOURNAL, 2023, 56 (01): : 22 - 27
[10] A real-world perspective on the prevalence and treatment of heart failure with a reduced ejection fraction but no specific or only mild symptoms
Beygui, Farzin
Anguita, Manuel
Tebbe, Ulrich
Comin-Colet, Josep
Galinier, Michel
Bramlage, Peter
Turgonyi, Eva
Lins, Katharina
Imekraz, Lynda
de Frutos, Trinidad
Bohm, Michael
HEART FAILURE REVIEWS, 2015, 20 (05) : 545 - 552

← 1 2 3 4 5 →